News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
618,110 Results
Type
Article (37686)
Company Profile (125)
Press Release (580299)
Multimedia
Podcasts (80)
Webinars (6)
Section
Business (184886)
Career Advice (1868)
Deals (31416)
Drug Delivery (103)
Drug Development (70435)
Employer Resources (139)
FDA (15407)
Job Trends (13246)
News (310411)
Policy (30097)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (6)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2151)
Academic (2)
Accelerated approval (6)
Adcomms (15)
Allergies (79)
Alliances (48540)
ALS (76)
Alzheimer's disease (1170)
Antibody-drug conjugate (ADC) (95)
Approvals (15427)
Artificial intelligence (222)
Autoimmune disease (21)
Automation (15)
Bankruptcy (278)
Best Places to Work (10383)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (82)
Bladder cancer (53)
Brain cancer (18)
Breast cancer (225)
Cancer (1821)
Cardiovascular disease (152)
Career advice (1591)
Career pathing (23)
CAR-T (136)
Cell therapy (398)
Cervical cancer (21)
Clinical research (57284)
Collaboration (763)
Compensation (279)
Complete response letters (19)
COVID-19 (2281)
CRISPR (35)
C-suite (191)
Cystic fibrosis (85)
Data (1876)
Decentralized trials (2)
Denatured (27)
Depression (30)
Diabetes (246)
Diagnostics (6080)
Digital health (16)
Diversity (3)
Diversity, equity & inclusion (34)
Drug discovery (111)
Drug pricing (85)
Drug shortages (29)
Duchenne muscular dystrophy (82)
Earnings (77247)
Editorial (34)
Employer branding (17)
Employer resources (120)
Events (92353)
Executive appointments (617)
FDA (16508)
Featured Employer (37)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (7)
Funding (604)
Gene editing (87)
Generative AI (23)
Gene therapy (279)
GLP-1 (645)
Government (3980)
Grass and pollen (5)
Guidances (46)
Healthcare (15777)
Huntington's disease (17)
IgA nephropathy (23)
Immunology and inflammation (88)
Indications (26)
Infectious disease (2404)
Inflammatory bowel disease (116)
Inflation Reduction Act (9)
Influenza (50)
Intellectual property (88)
Interviews (316)
IPO (14071)
IRA (37)
Job creations (3292)
Job search strategy (1356)
Kidney cancer (7)
Labor market (23)
Layoffs (381)
Leadership (16)
Legal (6972)
Liver cancer (63)
Lung cancer (265)
Lymphoma (125)
Machine learning (3)
Management (54)
Manufacturing (302)
MASH (53)
Medical device (12442)
Medtech (12447)
Mergers & acquisitions (17848)
Metabolic disorders (595)
Multiple sclerosis (63)
NASH (13)
Neurodegenerative disease (70)
Neuropsychiatric disorders (15)
Neuroscience (1590)
NextGen: Class of 2025 (5448)
Non-profit (3476)
Northern California (2147)
Now hiring (19)
Obesity (309)
Opinion (211)
Ovarian cancer (55)
Pain (72)
Pancreatic cancer (70)
Parkinson's disease (124)
Partnered (15)
Patents (211)
Patient recruitment (82)
Peanut (44)
People (49627)
Pharmaceutical (39)
Pharmacy benefit managers (13)
Phase I (17571)
Phase II (24878)
Phase III (19441)
Pipeline (1063)
Policy (117)
Postmarket research (2310)
Preclinical (7491)
Press Release (71)
Prostate cancer (95)
Psychedelics (24)
Radiopharmaceuticals (227)
Rare diseases (323)
Real estate (5528)
Recruiting (52)
Regulatory (21037)
Reports (32)
Research institute (1993)
Resumes & cover letters (275)
Rett syndrome (3)
RNA editing (3)
RSV (36)
Schizophrenia (57)
Series A (107)
Series B (66)
Service/supplier (9)
Sickle cell disease (48)
Southern California (1846)
Special edition (11)
Spinal muscular atrophy (135)
Sponsored (26)
Startups (3074)
State (1)
Stomach cancer (10)
Supply chain (67)
Tariffs (22)
The Weekly (52)
United States (19138)
Vaccines (586)
Venture capitalists (25)
Weight loss (213)
Women's health (28)
Worklife (14)
Date
Today (157)
Last 7 days (428)
Last 30 days (2245)
Last 365 days (29265)
2025 (8145)
2024 (31184)
2023 (35755)
2022 (46454)
2021 (50504)
2020 (49107)
2019 (41467)
2018 (31251)
2017 (30517)
2016 (29548)
2015 (34450)
2014 (27414)
2013 (23610)
2012 (25058)
2011 (25414)
2010 (23272)
Location
Africa (736)
Alabama (48)
Alaska (6)
Arizona (163)
Arkansas (13)
Asia (38196)
Australia (6253)
California (4852)
Canada (1717)
China (478)
Colorado (232)
Connecticut (230)
Delaware (123)
Europe (82746)
Florida (762)
Georgia (191)
Hawaii (1)
Idaho (47)
Illinois (474)
India (24)
Indiana (288)
Iowa (7)
Japan (145)
Kansas (90)
Kentucky (12)
Louisiana (8)
Maine (66)
Maryland (799)
Massachusetts (3629)
Michigan (217)
Minnesota (290)
Mississippi (1)
Missouri (77)
Montana (26)
Nebraska (16)
Nevada (54)
New Hampshire (59)
New Jersey (1576)
New Mexico (26)
New York (1425)
North Carolina (861)
North Dakota (7)
Northern California (2147)
Ohio (171)
Oklahoma (12)
Oregon (29)
Pennsylvania (1118)
Puerto Rico (10)
Rhode Island (28)
South America (1106)
South Carolina (19)
South Dakota (1)
Southern California (1846)
Tennessee (86)
Texas (732)
Utah (152)
Virginia (134)
Washington D.C. (46)
Washington State (461)
West Virginia (3)
Wisconsin (48)
618,110 Results for "spectrum chemicals and laboratory products".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spectrum Vascular Welcomes New Executive Leadership
April 14, 2025
·
4 min read
Press Releases
CLS Health Introduces Full-Spectrum Eye Care at Clear Lake Campus
April 15, 2025
·
2 min read
Press Releases
Spectrum Dynamics Medical Appoints Tomer Gabay as its New Chief Executive Officer
March 14, 2025
·
1 min read
Pharm Country
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
AngioDynamics, Inc. announced that it has completed the sale of its PICC and Midline product portfolios to Spectrum Vascular, an innovative medical device company focused on vascular access and medication management, for up to $45 million in cash.
February 15, 2024
·
6 min read
Press Releases
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases
March 7, 2025
·
5 min read
Press Releases
LG Chem and Acies Bio Collaborate to Advance Sustainable Production of Chemicals
December 5, 2024
·
4 min read
Press Releases
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular
January 13, 2025
·
2 min read
Press Releases
Kraig Biocraft Laboratories Secures New Investment License Allowing for Further Production Scale-Up
January 23, 2025
·
3 min read
Pharm Country
A Novel Broad-Spectrum Antiviral with Activity Against Influenza A
NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral activity spectrum of NV-387 includes Influenza A viruses, possibly including Bird Flu H5N1 virus as well.
May 6, 2024
·
8 min read
Pharm Country
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral activity spectrum of NV-387 includes activity against orthopoxvirus family, with both inhalation and skin abrasion modes of infection acquisition.
May 8, 2024
·
8 min read
1 of 61,811
Next
